Dupen Laboratories Private Limited

Dupen Laboratories Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
CIN U24239MH1976PTC103955 Incorporated 23 March 1976 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹8.2 Cr
▼ 35% YoY
Net loss · FY 2025
₹63.72 Lakh
Net margin -7.8%
EBITDA · FY 2025
-₹49.39 Lakh
EBITDA margin -6%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹9.86 Lakh
Issued & subscribed
Satisfied charges
₹3.19 Cr
No open charges
Company age
50 yrs
Est. 1976
Employees · EPFO
6
Provident fund records

About Dupen Laboratories Private Limited

Data last updated:

Dupen Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 23 March 1976 and has been in existence for over 50 years.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH1976PTC103955. Its GSTIN is 27AAACD2943E1ZZ (Maharashtra). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹9.86 Lakh. It was formerly known as Rama Pharma Lab Pvt Ltd and Rama Laboratories Pvt Ltd. It is led by directors including Rajeshwari Datla (Managing Director) and Nagendra Varaprasad Nadimpally (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.2 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net loss of ₹63.72 Lakh (net margin -7.8%) and EBITDA of -₹49.39 Lakh (EBITDA margin -6%). Revenue has declined at a compounded annual rate (CAGR) of 25% over three years and 13% over five years.

The company has about 6 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Dupen Laboratories. As per MCA filings, the company has satisfied charges of ₹3.19 Cr on record. Court records list 30 cases involving the company, including 8 filed by the company and 22 filed against it; 18 cases are pending.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dupenlabs.com.

Company details

CIN U24239MH1976PTC103955
Registration Number 103955
Incorporation Date 23 March 1976
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant

Name history

Dupen Laboratories has undergone 2 name changes throughout its history. The company was previously known as Rama Pharma Lab Pvt Ltd, and Rama Laboratories Pvt Ltd. The current legal name is Dupen Laboratories Private Limited.

Company NameStatus
Dupen Laboratories Private LimitedCurrent
Rama Pharma Lab Pvt LtdPrevious
Rama Laboratories Pvt LtdPrevious

CIN history

Dupen Laboratories has one previous CIN (Corporate Identification Number): U24239MH1996PTC103955. The current CIN is U24239MH1976PTC103955, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24239MH1976PTC103955Current
U24239MH1996PTC103955Previous

Contact details

Dupen Laboratories Private Limited's registered office is in Mumbai, Maharashtra. Its website is dupenlabs.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    Dheeraj Heritage 18 5th Floor, S. V. Road Near Best Depot, Mumbai, Maharashtra, India – 400054
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Dupen Laboratories Private Limited, buy the company report.

Comprehensive company report
Dupen Laboratories Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Dupen Laboratories operates one associated brand: Dupen Laboratories. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and markets its own pharmaceutical brands while providing CMO services.dupenlabs.com

Business activity

The main business activity of Dupen Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Dupen Laboratories Private Limited, buy the company report.

Financials of Dupen Laboratories Private Limited

FY 2025 filings available

Dupen Laboratories Private Limited reported revenue of ₹8.2 Cr (down 35% YoY) for FY 2025.

Revenue · FY 2025
₹8.2 Cr ▼ 35%
Net loss · FY 2025
₹63.72 Lakh margin -7.8%
EBITDA · FY 2025
-₹49.39 Lakh margin -6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 35%
3 years · compounded
▼ 25%
5 years · compounded
▼ 13%
EBITDA CAGR growth
1 year
▼ 109%
3 years · compounded
▼ 27%
5 years · compounded
▲ 17%

Revenue has declined at a compounded annual rate (CAGR) of 13% over five years, including a 35% fall in the latest year. EBITDA fell 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹49.39 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹63.72 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-6%
Net Profit Margin-7.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dupen Laboratories Private Limited, buy the company report.

Board of directors of Dupen Laboratories Private Limited

Dupen Laboratories has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajeshwari DatlaManaging Director01 Jan 199531 Years 10 MonthsCurrent
Nagendra Varaprasad NadimpallyWhole-Time Director01 Jan 20179 Years 10 MonthsCurrent
Anupama Datla DesaiDirector15 Dec 200421 Years 10 MonthsCurrent

Peer comparison

Dupen Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Mars Pharma Private Limited₹8.22 Cr (FY 2024)39.0%Hyderabad, Telangana, India
Dupen Laboratories Private Limitedthis company₹8.2 Cr (FY 2025)-₹63.72 Lakh-7.8%-35.0%6Mumbai, Maharashtra, India
KFS Biotech Private Limited₹8.15 Cr (FY 2025)9.0%Baddi, Himachal Pradesh, India
Gujarat Mitul Petro -Pharma Private Limited₹8.15 Cr (FY 2024)-19.0%Vadodara, Gujarat, India
KST Pharmaceuticals Private Limited₹8.12 Cr (FY 2024)552.0%Hyderabad, Telangana, India

To see the full peer comparison of Dupen Laboratories Private Limited, buy the company report.

Auditor

Dupen Laboratories Private Limited is audited by M M Nissim & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
M M Nissim & Co.FY 2023107122W

Shareholding

The shareholding of Dupen Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2023FY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Dupen Laboratories Private Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹3.19 Cr
Breakdown by lending institutions
Corporation Bank₹2.55 Cr
Bank of Baroda₹0.60 Cr
Gujarat State Financial Corporation₹0.04 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Nov 200910193459Corporation Bank₹2.55 CrSatisfied
05 Nov 199390347524Bank of Baroda₹37 LakhSatisfied
28 Mar 199290348065Bank of Baroda₹9 LakhSatisfied
19 Jul 199090348011Bank of Baroda₹10.2 LakhSatisfied
30 Jan 198690346185Bank of Baroda₹2 LakhSatisfied

To see the full charge records of Dupen Laboratories Private Limited, buy the company report.

Total charge records: 8 View all charges

MSME payment delays

Dupen Laboratories Private Limited has 3 MSME Form 1 returns on record between 2019 and 2024, listing 27 overdue payments to 22 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 22)

SupplierAmount dueDue sinceReported on
an individual supplier
an individual supplier
an individual supplier
an individual supplier
an individual supplier

To see the full MSME payment records of Dupen Laboratories Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Employees & EPFO

Dupen Laboratories Private Limited has a workforce of 6 employees on its EPFO records as of Aug 26, 2024, across 1 active EPFO establishment.

Employee count
6
Active EPFO establishments
1
Employee growth
-14.29%

GST

Dupen Laboratories has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
27AAACD2943E1ZZMaharashtraActive01 Jul 2017
24AAACD2943E1Z5GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Dupen Laboratories Private Limited, buy the company report.

Recent activity

Dupen Laboratories Private Limited has 5 board changes on record since 1995: 3 appointments and 2 cessations. The latest: Nagendra Varaprasad Nadimpally was appointed as Whole-Time Director on 01 Jan 2017.

AGM
Dupen Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dupen Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Charges
A charge registered on 19 Jul 1990 via Charge ID 90348011 with Bank Of Baroda was fully satisfied on 30 Nov 2022.
Charges
A charge registered on 30 Jan 1986 via Charge ID 90346185 with Bank Of Baroda was fully satisfied on 30 Nov 2022.
Charges
A charge registered on 30 Jan 1986 via Charge ID 90347828 with Bank Of Baroda was fully satisfied on 30 Nov 2022.
Charges
A charge registered on 05 Nov 1993 via Charge ID 90347524 with Bank Of Baroda was fully satisfied on 07 Nov 2022.
Charges
A charge registered on 28 Mar 1992 via Charge ID 90348065 with Bank Of Baroda was fully satisfied on 07 Nov 2022.
Charges
A charge registered on 11 Nov 2009 via Charge ID 10193459 with Corporation Bank was fully satisfied on 17 Nov 2021.
Appointed
Nagendra Varaprasad Nadimpally was appointed as Whole-Time Director.
Ceased
Preeti Thakkar ceased to be Director.
Ceased
Chandrashekar Rao ceased to be Director.
Charges
A charge with Corporation Bank amounted to Rs. 255.00 Lakh with Charge ID 10193459 was registered on 11 Nov 2009.

15 earlier events are in the company report.

Frequently asked questions

Dupen Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 23 March 1976 (50+ years old) and is registered under CIN U24239MH1976PTC103955.

Dupen Laboratories has 3 current directors:

The latest financial statements of Dupen Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dupen Laboratories is 27AAACD2943E1ZZ, registered in Maharashtra. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 24AAACD2943E1Z5 (Gujarat).

The CIN (Corporate Identification Number) of Dupen Laboratories is U24239MH1976PTC103955. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dupen Laboratories has 30 court cases on record: 8 filed by the company and 22 filed against it. 18 are pending. Most are in the district courts.

Dupen Laboratories was incorporated on 23 March 1976, making it 50+ years old. It is registered with the Registrar of Companies, Mumbai.

The peers of Dupen Laboratories by revenue are Mars Pharma Private Limited, KFS Biotech Private Limited, Gujarat Mitul Petro -Pharma Private Limited, KST Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Nagendra Varaprasad Nadimpally was appointed as Whole-Time Director on 01 Jan 2017. Preeti Thakkar ceased to be Director on 01 Jan 2017. Chandrashekar Rao ceased to be Director on 02 Apr 2016. Dupen Laboratories has 5 board changes on record in total.

Dupen Laboratories has 3 MSME Form 1 returns on record between 2019 and 2024, listing 27 overdue payments to 22 micro and small suppliers. The latest return was filed on 03 May 2024.

Dupen Laboratories can be reached through the website dupenlabs.com. Its registered office is in Mumbai, Maharashtra, India.

The registered office of Dupen Laboratories is at Dheeraj Heritage 18 5th Floor, S. V. Road Near Best Depot, Mumbai, Maharashtra, India – 400054.